148 related articles for article (PubMed ID: 6123462)
1. [Biochemistry of neuronal transmission. Pharmacology of parkinsonism].
Lombardo L
Gac Med Mex; 1981 Dec; 117(12):476-8. PubMed ID: 6123462
[No Abstract] [Full Text] [Related]
2. [Abnormal neurotransmission in neurological diseases (author's transl)].
Toru M
Tanpakushitsu Kakusan Koso; 1979; 24(2):150-9. PubMed ID: 35816
[No Abstract] [Full Text] [Related]
3. Potential nondopaminergic drugs for Parkinson's disease.
Silverdale MA; Fox SH; Crossman AR; Brotchie JM
Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
[No Abstract] [Full Text] [Related]
4. Problems in the contemporary treatment of parkinsonism.
Eadie MJ
Med J Aust; 1985 Jan; 142(2):113-7. PubMed ID: 2981393
[No Abstract] [Full Text] [Related]
5. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
Calabresi P; Mercuri NB; Di Filippo M
Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
[No Abstract] [Full Text] [Related]
6. Developments in understanding the physiology and pharmacology of parkinsonism.
Teräväinen H; Calne DB
Acta Neurol Scand; 1979 Jul; 60(1):1-11. PubMed ID: 40381
[TBL] [Abstract][Full Text] [Related]
7. Biochemistry of the basal ganglia.
Fahn S
Adv Neurol; 1976; 14():59-89. PubMed ID: 7932
[No Abstract] [Full Text] [Related]
8. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
Grace AA
Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
[TBL] [Abstract][Full Text] [Related]
9. Developments in the pharmacology and therapeutics of parkinsonism.
Calne DB
Ann Neurol; 1977 Feb; 1(2):111-9. PubMed ID: 18978
[No Abstract] [Full Text] [Related]
10. [Cerebral hemodynamics and clinical pharmacology in Parkinson disease].
Marc-Vergnes JP; Celsis P; Montastruc JL; Demonet JF; Agniel A; Rascol O; Viallard G; Doyon B; Rascol A
Therapie; 1988; 43(2):83-8. PubMed ID: 3406932
[No Abstract] [Full Text] [Related]
11. [Thoughts on the neurobiological aspects of Parkinson syndrome].
Sommer H
Psychiatr Neurol Med Psychol (Leipz); 1986 Feb; 38(2):86-90. PubMed ID: 3010357
[TBL] [Abstract][Full Text] [Related]
12. [Progresses in the study of unbalance of basal ganglia neurotransmitters in Parkinson's disease].
Sun ZL; Jia J; Yu F
Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):427-30. PubMed ID: 22363981
[No Abstract] [Full Text] [Related]
13. Medications for Parkinson's disease.
Whitney CM
Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
[No Abstract] [Full Text] [Related]
14. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease.
Starr MS
Synapse; 1995 Apr; 19(4):264-93. PubMed ID: 7792721
[TBL] [Abstract][Full Text] [Related]
15. [Changing drug therapy of Parkinson disease].
Rinne UK
Duodecim; 1993; 109(20):1763-8. PubMed ID: 7736999
[No Abstract] [Full Text] [Related]
16. [Problems and future perspectives in the treatment of Parkinson's disease].
Hens L; Hellemans J
Tijdschr Gerontol Geriatr; 1982 Aug; 13(4):147-54. PubMed ID: 6127822
[TBL] [Abstract][Full Text] [Related]
17. [Dopamine receptors and dyskinesias].
Linazasoro G
Neurologia; 1998 Apr; 13(4):206-7. PubMed ID: 9608763
[No Abstract] [Full Text] [Related]
18. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
Morelli M; Di Paolo T; Wardas J; Calon F; Xiao D; Schwarzschild MA
Prog Neurobiol; 2007 Dec; 83(5):293-309. PubMed ID: 17826884
[TBL] [Abstract][Full Text] [Related]
19. Advances in the neuropharmacology of Parkinsonism.
Calne DB; Kebabian J; Silbergeld E; Evarts E
Ann Intern Med; 1979 Feb; 90(2):219-29. PubMed ID: 36020
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
